Menu

CEL-SCI Corporation CVM

Full chart Compare
Set alert

Price alert · CVM

All alert types
1.35 USD -0.10 (-6.90%)

At closeNov 9, 2026, 4:00 PM EST

1.39 +0.04 +2.96%

After hours · Nov 9, 4:00 PM ET

1.35 Day range 1.53
0.89 52-week range 7.80
YTD
-74.33%
1 year
-80.82%

Discussion (163)

Sign in to join the discussion

alsp@qx.net CVM 2 years ago #71

You guys are looking at trading patterns and charts. If you are trading around this stock you are going to miss the big move. CVM is more of a cult stock. You can’t hit a grand slam if you are squaring off to bunt. This could be a $150 stock. You can have an option pool to trade around but be sure you have a large core of shares so you and you family can buy a vacation home or pay for college educations. Do you want a used VW or a Bentley?

alsp@qx.net CVM 2 years ago #72

I have posted numerous times MK has shown efficacy and with ZERO toxicity. You can’t keep a lid on that data forever big pharma! The share price at some time will explode. Short covering will pop this above $5 which will put the stock above a price threshold which will get it noticed. Then there will be a FOMO feeding frenzy.

alsp@qx.net CVM 2 years ago #73

Prior to dilution this was a $150-$200 stock with FDA approval.

alsp@qx.net CVM 3 years ago #75

Look at the Jan $20 call price action

alsp@qx.net CVM 3 years ago #76

We may be on the verge of a parabolic move. These aren’t shares of Exxon. News/information is driving this move- not trading rudiments. And when it is one of the biggest % movers 2 or 3 days in a row it will get noticed. Then the traders (and people looking for a pot of gold) pile in.

alsp@qx.net CVM 3 years ago #77

It looks like somebody knows something.

alsp@qx.net CVM 3 years ago #78

They don’t need another dilution. They need a partner for marketing

alsp@qx.net CVM 3 years ago #79

SA - this is an orphan drug with shown effectiveness and ZERO TOXICITY. That is enough for some type of approval given the treatment group has a fatal illness and current treatments have a high side effect profile.
I feel this is more about protecting Keytruda than protecting patients.